Approval · United States
Zepbound
U.S. Food and Drug Administration · Nov 8, 2023
Approval record
- Asset
- Tirzepatide
- Brand name
- Zepbound
- Generic name
- tirzepatide
- Indication
- Obesity
- Jurisdiction
- United States
- Regulator
- U.S. Food and Drug Administration
- Approval date
- Nov 8, 2023
- Company
- Eli Lilly
Sources
- regulatoryprimary record
FDA approves Mounjaro (tirzepatide) for adults with type 2 diabetes
U.S. Food and Drug Administration · FDA News Release · May 13, 2022